ThermoGenesis Holdings, Inc. THMO OTC

Other OTC • Healthcare • Medical - Devices • US • USD

ThermoGenesis Holdings, Inc. (THMO) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

THMO Analyst Ratings

Buy

Ratings

1 Buy

Based on 1 analysts giving stock ratings to ThermoGenesis Holdings, Inc. in the past 3 months

Rating breakdown

Buy

1 100%

100%

Buy

1 analysts

Hold

0 analysts

Sell

0 analysts

People Also View

RPID

Rapid Micro Biosystems, Inc.

$2.19

+2.82%

VVOS

Vivos Therapeutics, Inc.

$1.35

+10.66%

SINT

Sintx Technologies, Inc.

$2.80

-2.44%

TLIS

Talis Biomedical Corporation

$2.84

+0.00%

HSCS

Heart Test Laboratories, Inc.

$1.97

-0.76%

RMED

Ra Medical Systems, Inc.

$0.59

+10.00%

RSLS

ReShape Lifesciences Inc.

$3.92

+22.50%

BBLG

Bone Biologics Corporation

$1.26

+2.44%

ThermoGenesis Holdings, Inc. THMO OTC

THMO Analyst Ratings

People Also View

Get Undervalued Stock Alerts